Literature DB >> 25392873

[Not Available].

Hartmut T Klages.   

Abstract

Mesh：

Year:  2014        PMID： 25392873     DOI： 10.1007/s00066-014-0729-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  9 in total

1.  [Comparison of various fractionation schedule in curative radiotherapy alone of locally advanced head and neck tumors].

Authors:  M Baumann; H T Klages
Journal:  Strahlenther Onkol       Date:  2001-03       Impact factor: 3.621

Review 2.  [Multiple significance tests and their importance in the judging of results. A quality analysis of the journal Strahlentherapie und Onkologie].

Authors:  H P Beck-Bornholdt; H H Dubben
Journal:  Strahlenther Onkol       Date:  2000-08       Impact factor: 3.621

3.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

Authors:  Arlene A Forastiere; Helmuth Goepfert; Moshe Maor; Thomas F Pajak; Randal Weber; William Morrison; Bonnie Glisson; Andy Trotti; John A Ridge; Clifford Chao; Glen Peters; Ding-Jen Lee; Andrea Leaf; John Ensley; Jay Cooper
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245

4.  Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.

Authors:  Jean Bourhis; Christian Sire; Pierre Graff; Vincent Grégoire; Philippe Maingon; Gilles Calais; Bernard Gery; Laurent Martin; Marc Alfonsi; Patrick Desprez; Thierry Pignon; Etienne Bardet; Michel Rives; Lionel Geoffrois; Nicolas Daly-Schveitzer; Sok Sen; Claude Tuchais; Olivier Dupuis; Stéphane Guerif; Michel Lapeyre; Véronique Favrel; Marc Hamoir; Antoine Lusinchi; Stéphane Temam; Antonella Pinna; Yun Gan Tao; Pierre Blanchard; Anne Aupérin
Journal:  Lancet Oncol       Date:  2012-01-18       Impact factor: 41.316

5.  Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.

Authors:  Jonathan J Beitler; Qiang Zhang; Karen K Fu; Andy Trotti; Sharon A Spencer; Christopher U Jones; Adam S Garden; George Shenouda; Jonathan Harris; Kian K Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-07       Impact factor: 7.038

6.  A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.

Authors:  K K Fu; T F Pajak; A Trotti; C U Jones; S A Spencer; T L Phillips; A S Garden; J A Ridge; J S Cooper; K K Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

7.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Authors:  Jean-Pierre Pignon; Aurélie le Maître; Emilie Maillard; Jean Bourhis
Journal:  Radiother Oncol       Date:  2009-05-14       Impact factor: 6.280

Review 8.  Hyperfractionated or accelerated radiotherapy for head and neck cancer.

Authors:  Bertrand Baujat; Jean Bourhis; Pierre Blanchard; Jens Overgaard; Kian K Ang; Michelle Saunders; Aurélie Le Maître; Jacques Bernier; Jean Claude Horiot; Emilie Maillard; Thomas F Pajak; Michael G Poulsen; Abderrahmane Bourredjem; Brian O'Sullivan; Werner Dobrowsky; Hliniak Andrzej; Krzystof Skladowski; John H Hay; Luiz Hj Pinto; Karen K Fu; Carlo Fallai; Richard Sylvester; Jean Pierre Pignon
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

9.  A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.

Authors:  W Budach; T Hehr; V Budach; C Belka; K Dietz
Journal:  BMC Cancer       Date:  2006-01-31       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.